PD mice treated with sodium butyrate showed improvements in neurobehavioral impairment, prevented dopaminergic generation, attenuated the PD-associated disruption of BBB, and increased colonic GLP-1 and brain GLP-1R [179]. The gene discussed is GCG; the disease is Parkinson disease.